Ridgewood Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Buy
+10,710
New +$1.24M 0.53% 53
2025
Q3
$1.88M Buy
23,338
+1,859
+9% +$153K 0.79% 29
2025
Q2
$1.7M Buy
21,479
+8,546
+66% +$679K 0.73% 31
2025
Q1
$1.08M Buy
12,933
+5,929
+85% +$554K 0.51% 56
2024
Q4
$697K Buy
7,004
+5,668
+424% +$584K 0.34% 88
2024
Q3
$152K Hold
1,336
0.08% 197
2024
Q2
$165K Buy
+1,336
New +$172K 0.08% 190
2023
Q3
Sell
-1,336
Closed -$154K 534
2023
Q2
$154K Sell
1,336
-138
-9% -$15.7K 0.09% 199
2023
Q1
$157K Sell
1,474
-3,986
-73% -$430K 0.1% 205
2022
Q4
$606K Sell
5,460
-3,234
-37% -$331K 0.43% 80
2022
Q3
$749K Hold
8,694
0.62% 46
2022
Q2
$793K Sell
8,694
-544
-6% -$48.2K 0.62% 46
2022
Q1
$758K Sell
9,238
-2,156
-19% -$170K 0.5% 63
2021
Q4
$873K Sell
11,394
-7,092
-38% -$565K 0.55% 57
2021
Q3
$1.39M Sell
18,486
-696
-4% -$52.9K 0.94% 19
2021
Q2
$1.49M Buy
19,182
+2,764
+17% +$206K 0.96% 18
2021
Q1
$1.21M Buy
16,418
+3,610
+28% +$266K 0.74% 38
2020
Q4
$1.01M Hold
12,808
0.8% 30
2020
Q3
$1.01M Sell
12,808
-439
-3% -$34.4K 0.79% 30
2020
Q2
$977K Buy
13,247
+9,118
+221% +$686K 0.81% 28
2020
Q1
$303K Sell
4,129
-4
-0.1% -$314 0.31% 101
2019
Q4
$359K Hold
4,133
0.25% 116
2019
Q3
$332K Buy
4,133
+101
+3% +$8.1K 0.26% 121
2019
Q2
$323K Sell
4,032
-6,343
-61% -$486K 0.25% 123
2019
Q1
$823K Sell
10,375
-6,446
-38% -$482K 0.68% 38
2018
Q4
$1.14M Hold
16,821
0.91% 22
2018
Q3
$1.14M Buy
16,821
+503
+3% +$32K 0.91% 22
2018
Q2
$945K Buy
16,318
+148
+0.9% +$8.35K 0.84% 26
2018
Q1
$840K Buy
16,170
+4,924
+44% +$266K 0.77% 37
2017
Q4
$604K Buy
11,246
+2,519
+29% +$140K 0.54% 52
2017
Q3
$533K Buy
8,727
+1,864
+27% +$113K 0.51% 52
2017
Q2
$420K Sell
6,863
-1,109
-14% -$67.5K 0.42% 67
2017
Q1
$483K Buy
7,972
+170
+2% +$10.3K 0.52% 51
2016
Q4
$438K Buy
+7,802
New +$457K 0.52% 53

Other funds holding MRK

Ridgewood Investments's MRK Position: Q1 2026 in Review

Ridgewood Investments opened a new position in Merck (MRK) in Q1 2026: 10,710 shares worth $1.29M. The stake represents 0.53% of the portfolio and ranks #53 among its holdings. This is a return to the name: Ridgewood Investments previously reported a position in MRK as recently as Q3 2025.

Ridgewood Investments first reported a position in MRK in Q4 2016 and has held it in 34 quarters since. The position peaked at $1.88M in Q3 2025. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Ridgewood Investments held 10,710 shares of Merck worth $1.29M as of Q1 2026.
  • Merck was a new Ridgewood Investments position in Q1 2026.
  • Merck made up 0.53% of Ridgewood Investments's portfolio in Q1 2026, its #53 holding.
  • Ridgewood Investments first reported a position in Merck in Q4 2016 and has held it in 34 quarters since.
  • Ridgewood Investments's Merck position peaked at $1.88M in Q3 2025.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Ridgewood Investments's 13F filing for Q1 2026, filed 3 Apr 2026.